Effects of 2-methoxyestradiol on endometrial carcinoma xenografts

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 5, 2007, Pages 315-320

  Li, Li ^a,b   Yu, Fengling ^b   Wu, Xiaohua ^b   Cheng, Jianxin ^b   Ulmsten, Ulf ^a   Fu, Xin ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

2 Methoxyestradiol; Human endometrial carcinoma; SCID mice

Indexed keywords

2 METHOXYESTRADIOL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLINE; KI 67 ANTIGEN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CHEMISTRY; BODY WEIGHT; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG DOSE INCREASE; ENDOMETRIUM CARCINOMA; EPITHELIUM CELL; FEMALE; HEART; KIDNEY; LIVER; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN; TISSUE NECROSIS; TUMOR VOLUME; TUMOR XENOGRAFT; UREA NITROGEN BLOOD LEVEL; UTERUS;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; HUMANS; MICE; MICE, SCID; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34248199978     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0173-x     Document Type: Article

References (23)

1. Bu S, Blaukat A, Fu X, Heldin NE, Landstrom M (2002) Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett 531(2):141-151
2. Dingli D, Timm M, Russell SJ, Witzig TE, Rajkumar SV (2002) Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. Clin Cancer Res 8(12):3948-3954
3. Dubey RK, Gillespie DG, Zacharia LC, Rosselli M, Korzekwa KR, Fingerle J, Jackson EK (2000) Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms. Biochem Biophys Res Commun 278(1):27-33
4. Dubey RK, Gillespie DG, Zacharia LC, Rosselli M, Imthurn B, Jackson EK (2002) Methoxyestradiols mediate the antimitogenic effects of locally applied estradiol on cardiac fibroblast growth. Hypertension 39(2 Pt 2):412-417
5. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368(6468):237-239
6. Huober JB, Nakamura S, Meyn R, Roth JA, Mukhopadhyay T (2000) Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48(4):1127-1137
7. Ireson CR, Chander SK, Purohit A, Perera S, Newman SP, Parish D, Leese MP, Smith AC, Potter BV, Reed MJ (2004) Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br J Cancer 90(4):932-937
8. Kameyama K, Takami H, Umemura S, Osamura YR, Wada N, Sugino K, Mimura T, Ito K (2000) PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas. Ann Surg Oncol 7:301-304
9. Kataoka M, Schumacher G, Cristiano RJ, Atkinson EN, Roth JA, Mukhopadhyay T (1998) An agent that increases tumor suppressor transgene product coupled with systemic transgene delivery inhibits growth of metastatic lung cancer in vivo. Cancer Res 58(21):4761-4765
10. Kinuya S, Kawashima A, Yokoyama K, Kudo M, Kasahara Y, Watanabe N, Shuke N, Bunko H, Michigishi T, Tonami N (2001) Anti-angiogenic therapy and radioimmunotherapy in colon cancer xenografts. Eur J Nucl Med 28(9):1306-1312
11. Klauber N, Parangi S, Flynn E, Hamel E, D'Amato RJ (1997) Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57(1):81-86
12. LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS (2002) 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62(13):3691-3697
13. Li L, Heldin NE, Grawé J, Ulmsten U, Fu X (2004) Induction of apoptosis or necrosis in human endometrial carcinoma cells by 2-methoxyestradiol. Anticancer Res 24(6):3983-3989
14. Lippert TH, Adlercreutz H, Berger MR, Seeger H, Elger W, Mueck AO (2003) Effect of 2-methoxyestradiol on the growth of methyl-nitroso-urea(MNU) induced rat mammary carcinoma. J Steroid Biochem Mol Biol 84(1):51-56
15. Miller KD, Murry DJ, Curry E, Haney LG, McClaskey N, Storniolo AM, Phillips E, Pribluda V, Gubish ER, Sledge GW (2002) A phase I study of 2-methoxyestradiol (2ME2) plus docetaxel (D) in patients (pts) with metastatic breast cancer (MBC). Presented at the 38th annual meeting of the American Society of Clinical Oncology, Orlando
16. Mooberry SL (2003) Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist Updat 6(6):355-361
17. Nishigaki I, Sasaguri Y, Yagi K (1995) Anti-proliferative effect of 2-methoxyestradiol on cultured smooth muscle cells from rabbit aorta. Atherosclerosis 113(2):167-170
18. Qadan LR, Perez-Stable CM, Anderson C, D'Ippolito G, Herron A, Howard GA, Roos BA (2001) 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer. Biochem Biophys Res Commun 285(5):1259-1266
19. Ryschich E, Werner J, Gebhard MM, Klar E, Schmidt J (2003) Angiogenesis inhibition with TNP-470, 2-methoxyestradiol, and paclitaxel in experimental pancreatic carcinoma. Pancreas 26(2):166-172
20. Schumacher G, Kataoka M, Roth JA, Mukhopadhyay T (1999) Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res 5(3):493-499
21. Sibonga JD, Lotinun S, Evans GL, Pribluda VS, Green SJ, Turner RT (2003) Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat. Endocrinology 144(3):785-792
22. Wassberg E (1999) Angiostatic treatment of neuroblastoma. Ups J Med Sci 104(1):1-24
23. Zacharia LC, Jackson EK, Gillespie DG, Dubey RK (2001) Catecholamines abrogate antimitogenic effects of 2-hydroxyestradiol on human aortic vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21(11):1745-1750